advertisement
Li Z 53
Showing records 1 to 25 | Display all abstracts from Li Z96016 Associated risk factors of postoperative pain after glaucoma surgery: a prospective study
Li Z
International Ophthalmology 2022; 42: 829-840
96424 Deep learning for automated glaucomatous optic neuropathy detection from ultra-widefield fundus images
Li Z
British Journal of Ophthalmology 2021; 105: 1548-1554
96331 Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes
Beykin G
American Journal of Ophthalmology 2021; 234: 223-234
96132 Association of the CYP39A1 G204E Genetic Variant with Increased Risk of Glaucoma and Blindness in Patients with Exfoliation Syndrome
Bell K; Ozaki M
Ophthalmology 2022; 129: 406-413
96424 Deep learning for automated glaucomatous optic neuropathy detection from ultra-widefield fundus images
Guo C
British Journal of Ophthalmology 2021; 105: 1548-1554
96331 Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes
Stell L
American Journal of Ophthalmology 2021; 234: 223-234
96016 Associated risk factors of postoperative pain after glaucoma surgery: a prospective study
Yao S; Ni Y
International Ophthalmology 2022; 42: 829-840
96424 Deep learning for automated glaucomatous optic neuropathy detection from ultra-widefield fundus images
Lin D
British Journal of Ophthalmology 2021; 105: 1548-1554
96331 Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes
Halim MS
American Journal of Ophthalmology 2021; 234: 223-234
96132 Association of the CYP39A1 G204E Genetic Variant with Increased Risk of Glaucoma and Blindness in Patients with Exfoliation Syndrome
Mori K; Mizoguchi T
Ophthalmology 2022; 129: 406-413
96016 Associated risk factors of postoperative pain after glaucoma surgery: a prospective study
Huang W
International Ophthalmology 2022; 42: 829-840
96331 Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes
Nuñez M
American Journal of Ophthalmology 2021; 234: 223-234
96424 Deep learning for automated glaucomatous optic neuropathy detection from ultra-widefield fundus images
Nie D
British Journal of Ophthalmology 2021; 105: 1548-1554
96331 Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes
Popova L
American Journal of Ophthalmology 2021; 234: 223-234
96016 Associated risk factors of postoperative pain after glaucoma surgery: a prospective study
Zheng W
International Ophthalmology 2022; 42: 829-840
96424 Deep learning for automated glaucomatous optic neuropathy detection from ultra-widefield fundus images
Zhu Y
British Journal of Ophthalmology 2021; 105: 1548-1554
96132 Association of the CYP39A1 G204E Genetic Variant with Increased Risk of Glaucoma and Blindness in Patients with Exfoliation Syndrome
Nakano S
Ophthalmology 2022; 129: 406-413
96331 Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes
Nguyen BT
American Journal of Ophthalmology 2021; 234: 223-234
96132 Association of the CYP39A1 G204E Genetic Variant with Increased Risk of Glaucoma and Blindness in Patients with Exfoliation Syndrome
Porporato N
Ophthalmology 2022; 129: 406-413
96016 Associated risk factors of postoperative pain after glaucoma surgery: a prospective study
Yang J
International Ophthalmology 2022; 42: 829-840
96424 Deep learning for automated glaucomatous optic neuropathy detection from ultra-widefield fundus images
Chen C; Zhao L
British Journal of Ophthalmology 2021; 105: 1548-1554
96331 Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes
Groth SL
American Journal of Ophthalmology 2021; 234: 223-234
96132 Association of the CYP39A1 G204E Genetic Variant with Increased Risk of Glaucoma and Blindness in Patients with Exfoliation Syndrome
Ikeda Y
Ophthalmology 2022; 129: 406-413
96016 Associated risk factors of postoperative pain after glaucoma surgery: a prospective study
Qin Y
International Ophthalmology 2022; 42: 829-840
96331 Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes
Dennis A
American Journal of Ophthalmology 2021; 234: 223-234
